Intervention Review

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

  1. Julia Bohlius1,*,
  2. Kurt Schmidlin1,
  3. Corinne Brillant2,
  4. Guido Schwarzer3,
  5. Sven Trelle1,
  6. Jerome Seidenfeld4,
  7. Marcel Zwahlen1,
  8. Mike J Clarke5,
  9. Olaf Weingart2,
  10. Sabine Kluge2,
  11. Margaret Piper6,
  12. Maryann Napoli7,
  13. Dirk Rades8,
  14. David Steensma9,
  15. Benjamin Djulbegovic10,
  16. Martin F Fey11,
  17. Isabelle Ray-Coquard12,
  18. Volker Moebus13,
  19. Gillian Thomas14,
  20. Michael Untch15,
  21. Martin Schumacher16,
  22. Matthias Egger17,
  23. Andreas Engert2

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 11 MAY 2009

DOI: 10.1002/14651858.CD007303.pub2

How to Cite

Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke MJ, Weingart O, Kluge S, Piper M, Napoli M, Rades D, Steensma D, Djulbegovic B, Fey MF, Ray-Coquard I, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A. Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007303. DOI: 10.1002/14651858.CD007303.pub2.

Author Information

  1. 1

    University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland

  2. 2

    University Hospital of Cologne, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, Cologne, Germany

  3. 3

    Insitute of Medical Biometry and Medical Informatics, German Cochrane Centre, Freiburg, Germany

  4. 4

    American Society of Clinical Oncology, Department of Cancer Policy and Clinical Affairs, Alexandria, VA, USA

  5. 5

    UK Cochrane Centre, Oxford, UK

  6. 6

    Blue Cross and Blue Shield Association, Technology Evaluation Center, Chicago, IL, USA

  7. 7

    Center for Medical Consumers, New York, USA

  8. 8

    University Hospital, Department of Radiation Oncology, Lübeck, Germany

  9. 9

    Mayo Clinic, Rochester, MN, USA

  10. 10

    Center for Evidence Based Medicine and Health Outcomes Research, University of South Florida, Professor of Medicine and Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA

  11. 11

    University and Inselspital Bern, Department of Medical Oncology, Bern, Switzerland

  12. 12

    Centre Léon Bérard, Lyon, France

  13. 13

    Academic Hospital Frankfurt am Main Höchst, Department of Gynecology, Frankfurt a.M., Germany

  14. 14

    University of Toronto, Odette Sunnybrook Cancer Centre, Toronto, Ontario, Canada

  15. 15

    Helios Hospital Berlin-Buch, Clinic for Gynaecology, Berlin, Germany

  16. 16

    Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, German Cochrane Center, Freiburg, Germany

  17. 17

    Institute of Social and Preventive Medicine, Institute of Social Medicine, Bern, Switzerland

*Julia Bohlius, Institute of Social and Preventive Medicine, University of Bern, Bern, 3012, Switzerland.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 JUL 2009


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >